Methodist Neurological Institute

Houston, Texas 77030

0 studies enrolling now · 18 studies all time

What they study most

ALS, ALS (Amyotrophic Lateral Sclerosis), Alzheimer's Disease, Ambulatory Care, Amyotrophic Lateral Sclerosis, Diabetes, Familial Amyotrophic Lateral Sclerosis, Glioblastoma Multiforme, Hereditary Spastic Paraparesis, Huntington's Disease, Lou Gehrig's Disease, Muscular Dystrophy, Duchenne

Studies at this site

• Ph1 T-Regulatory Cells in Amyotrophic Lateral Sclerosis — Completed
• An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 (Tofersen) in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) — Completed
• A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) — Status unconfirmed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• Phase 3 Study of Dexpramipexole in ALS — Completed
• A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Insulin Resistance Intervention After Stroke Trial — Completed
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early
• SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS) — Completed
• Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) — Completed
• Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) — Completed
• Gilenya in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD) — Completed
• High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis — Completed
• Clinical Trial Ceftriaxone in Subjects With ALS — Completed
• Safety, Tolerability, and Activity Study of ISIS SOD1Rx to Treat Familial Amyotrophic Lateral Sclerosis (ALS) Caused by SOD1 Gene Mutations — Completed